Notice ID: 5b9401238c234add96f822b26b7b2b57Award NoticeAwarded
6505--UPTRAVI Medication
Awarded on January 30, 2023. Full description on SAM.gov.
Awarded tounder 36C24623P0524 (source: SAM.gov award notice)• $160.4K
Overview
- Posted
- January 30, 2023
- Notice type
- Award Notice
Notice details
- Last updated
- Sep 9, 2025
- Award date
- Jan 30, 2023
- Award amount (SAM.gov award notice)
- $160.4K
Identifiers
- Solicitation number
- 36C24623P0524
- Notice ID
- 5b9401238c234add96f822b26b7b2b57
- Award number (PIID)
- 36C24623P0524
Description
NOTICE OF INTENT TO AWARD SOLE SOURCE Project Title: Uptravi 1600mcg Announcement No.: 36C24623P0524 The Government hereby submits a notice of intent to award a sole source Firm-Fixed-Price, open market, purchase order for Uptravi medication. Selexipag lowers blood pressure in your lungs by dilating (widening) blood vessels that supply blood to the lungs. Selexipag is used to treat pulmonary arterial hypertension (PAH). Selexipag helps keep your condition from getting worse and helps lower your risk of needing to be hospitalized for PAH. The total estimated value is $175,014.36. Market research has determined there are no generic forms of this drug and Actelion Pharmaceuticals a large business are the sole manufacturers of this drug. Actelion Pharmaceuticals utilizes Accredo Health Group a large business as their authorized distributors. Responses to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the mission objective of the Fayetteville VAMC. The determination not to compete this proposed contract action is solely within the discretion of the Government. Information received will normally be considered for the purposes of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice. This is not a request for quote or proposals. Questions or comments to this Notice of Intent should be directed to Contracting Specialist, Isaac Hernandez at Isaac.Hernandez@va.gov (no phone calls/voice mail messages regarding questions will be accepted and will not received a response). Please indicate in the subject of your email: Notice of Intent Question Submission 36C24623P0524.
Award Overview
Award Number
36C24623P0524
Award Amount (SAM.gov award notice)
$160.4K
Award Date
Jan 30, 2023
Awardee
Awardee UEI
LERPSGUE3528
Original Solicitation
Notice ID: 5b9401238c234add96f822b26b7b2b57
Posted Date: Jan 30, 2023
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $13.4KSigned Apr 3, 2026
- $134.2KSigned Mar 5, 2026
- $11.2KSigned Jan 9, 2026
- $78.6KSigned Dec 23, 2025
- $8.5KSigned Sep 25, 2025
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C24623P0524- Awarded
This opportunity has been awarded.
- Special NoticeJan 23, 2023
6505--UPTRAVI Medication
- AwardedCurrentJan 30, 2023
6505--UPTRAVI Medication
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C24623P0524
Archive Date
Feb 13, 2023
Office Address
HAMPTON, VA, 23667